And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you may recall, our treasured signal to daydream about weekend plans. Our agenda is quite modest. We hope to catch up on our reading, take a few naps, promenade with the official mascots and take a few more naps. And what about you? This may be a good time to tidy up around your castle or take in a moving picture show or two. You could reach out to someone special or maybe plan a getaway. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Novartis (NVS) bribery scandal case that is causing a political ruckus in Greece may be returned to prosecutors, Ekathimerini reports. The parliament agreed to probe 10 politicians for allegedly accepting or facilitating bribes from the drug maker, which purportedly sought to boost sales of its medicines. But there may be two key problems with the case: a lack of evidence to substantiate the claims of protected witnesses and the fact that some of the alleged offenses have expired under the statute of limitations. Novartis has denied the allegations.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy